Simultaneous blocking of human toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guerin peptidoglycan

被引:125
作者
Uehori, J
Matsumoto, M
Tsuji, S
Akazawa, T
Takeuchi, O
Akira, S
Kawata, T
Azuma, I
Toyoshima, K
Seya, T
机构
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Immunol, Higashinari Ku, Osaka 5378511, Japan
[2] Nara Inst Sci & Technol, Dept Mol Immunol, Nara 6300101, Japan
[3] Org Pharmaceut Safety & Res, Tokyo 1000013, Japan
[4] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan
[5] Eisai & Co Ltd, Tsukuba Res Labs, Tsuchiura, Ibaraki 3002635, Japan
[6] Nakodate Natl Coll Technol, Hakodate, Hokkaido 0428501, Japan
关键词
D O I
10.1128/IAI.71.8.4238-4249.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Mycobacterium bovis bacillus Calmette-Guerin (BCG) cell wall skeleton (CWS) consists of mycolic acids, arabinogalactan, and peptidoglycan (PGN) and activates Toll-like receptor 2 (TLR2) and TLR4. Here we investigated the ability of the essential portion of highly purified BCG CWS to support the TLR agonist function by using the following criteria: myeloid dendritic cell (DC) maturation, i.e., tumor necrosis factor alpha (TNF-alpha) production and CD83/CD86 up-regulation. The purified PGN region was sufficient to activate TLR2 and TLR4 in mouse DCs and macrophages; in TLR2 and TLR4 double-knockout cells the BCG PGN-mediated TNF-alpha production ability was completely impaired. Likewise, stimulation with BCG CWS of HEK293 cells expressing either human TLR2 or TLR4, MD-2, and CD14 resulted in NF-kappaB activation as determined by a reporter assay. Notably, specific blockers; of extracellular human TLR2 (an original cocktail of monoclonal antibodies TLR2.45 and TH2.1) and TLR4 (E5531) inhibited BCG CWS-mediated NF-kappaB activation by 80%. Using this human TLR blocking system, we tested whether human myeloid DC maturation was TLR2 and TLR4 dependent. BCG PGN-mediated DC maturation was blocked by 70% by suppression of both TLR2 and TLR4 and by 30 to 40% by suppression of either of these TLRs. Similar but less profound suppression of BCG CWS-mediated DC maturation was observed. Hence, the presence of BCG PGN is a minimal requirement for activation of both TLR2 and TLR4 in human DCs, unlike the presence of PGNs of gram-positive bacteria, which activate only TLR2. Unexpectedly, however, BCG PGN, unlike BCG CWS, barely activated NF-kappaB in HEK293 cells coexpressing TLR2 plus TLR1, TLR2 plus TLR4, TLR2 plus TLR6, or TLR2 plus TLR10, suggesting that PGN receptors other than TLR2 and TLR4 present on human DCs but not on HEK293 cells are involved in TLR signaling for DC activation.
引用
收藏
页码:4238 / 4249
页数:12
相关论文
共 49 条
[1]   Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice [J].
Alexopoulou, L ;
Thomas, V ;
Schnare, M ;
Lobet, Y ;
Anguita, J ;
Schoen, RT ;
Medzhitov, R ;
Fikrig, E ;
Flavell, RA .
NATURE MEDICINE, 2002, 8 (08) :878-884
[2]   BIOLOGICALLY-ACTIVE COMPONENTS FROM MYCOBACTERIAL CELL-WALLS - ISOLATION AND COMPOSITION OF CELL-WALL SKELETON AND COMPONENT-P3 [J].
AZUMA, I ;
RIBI, EE ;
MEYER, TJ ;
ZBAR, B .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (01) :95-101
[3]   ADJUVANTICITY OF MYCOBACTERIAL CELL WALLS [J].
AZUMA, I ;
KISHIMOTO, S ;
YAMAMURA, Y ;
PETIT, JF .
JAPANESE JOURNAL OF MICROBIOLOGY, 1971, 15 (02) :193-+
[4]  
Besra Gurdyal S., 1994, P285
[5]  
BOMFORD R, 1980, CLIN EXP IMMUNOL, V39, P435
[6]   E5531, A PURE ENDOTOXIN ANTAGONIST OF HIGH POTENCY [J].
CHRIST, WJ ;
ASANO, O ;
ROBIDOUX, ALC ;
PEREZ, M ;
WANG, YA ;
DUBUC, GR ;
GAVIN, WE ;
HAWKINS, LD ;
MCGUINNESS, PD ;
MULLARKEY, MA ;
LEWIS, MD ;
KISHI, Y ;
KAWATA, T ;
BRISTOL, JR ;
ROSE, JR ;
ROSSIGNOL, DP ;
KOBAYASHI, S ;
HISHINUMA, L ;
KIMURA, A ;
ASAKAWA, N ;
KATAYAMA, K ;
YAMATSU, I .
SCIENCE, 1995, 268 (5207) :80-83
[7]   RELATIVE IMMUNOGENICITY OF STREPTOMYCIN-SENSITIVE AND STREPTOMYCIN-RESISTANT STRAINS OF BCG [J].
COLLINS, FM ;
MONTALBINE, V .
INFECTION AND IMMUNITY, 1973, 8 (03) :381-387
[8]   MD-2 enables toll-like receptor 2 (TLR2)-mediated responses to lipopolysaccharide and enhances TLR2-mediated responses to gram-positive and gram-negative bacteria and their cell wall components [J].
Dziarski, R ;
Wang, QL ;
Miyake, K ;
Kirschning, CJ ;
Gupta, D .
JOURNAL OF IMMUNOLOGY, 2001, 166 (03) :1938-1944
[9]  
Fenton M J, 1998, Curr Opin Hematol, V5, P72, DOI 10.1097/00062752-199801000-00012
[10]   Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide [J].
Flo, TH ;
Halaas, O ;
Lien, E ;
Ryan, L ;
Teti, G ;
Golenbock, DT ;
Sundan, A ;
Espevik, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :2064-2069